Nicod, Elena

Number of items: 17.
Article
  • Nicod, Elena, Maynou, Laia, Visintin, Erica, Cairns, John (2019). Why do health technology assessment drug reimbursement recommendations differ between countries? A parallel convergent mixed methods study. Health Economics, Policy and Law, 15(3), 386-402. https://doi.org/10.1017/S1744133119000239
  • Nicod, Elena (2017). Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four European countries. European Journal of Health Economics, 18(6), 715-730. https://doi.org/10.1007/s10198-016-0823-0
  • Jackson, Timothy L., Nicod, Elena, Angelis, Aris, Grimaccia, Federico, Pringle, Edward, Kanavos, Panos (2017). Pars plana vitrectomy for diabetic macular edema: a systematic review, meta-analysis, and synthesis of safety literature. Retina, 37(5), 886-895. https://doi.org/10.1097/IAE.0000000000001280
  • Nicod, Elena, Annemans, Lieven, Bucsics, Anna, Lee, Anne, Upadhyaya, Sheela, Facey, Karen (2017). HTA programme response to the challenges of dealing with orphan medicinal products: process evaluation in selected European countries. Health Policy, https://doi.org/10.1016/j.healthpol.2017.03.009
  • Nicod, Elena, Jackson, Timothy L., Grimaccia, Federico, Angelis, Aris, Costen, Marc, Haynes, Richard, Hughes, Edward, Pringle, Edward, Zambarakji, Hadi, Kanavos, Panos (2016). Direct cost of pars plana vitrectomy for the treatment of macular hole, epiretinal membrane and vitreomacular traction: a bottom-up approach. European Journal of Health Economics, 17(8), 991-999. https://doi.org/10.1007/s10198-015-0741-6
  • Nicod, Elena, Kanavos, Panos (2016). Scientific and social value judgments for orphan drugs in health technology assessment. International Journal of Technology Assessment in Health Care, 32(4), 218-232. https://doi.org/10.1017/S0266462316000416
  • Nicod, Elena, Kanavos, Panos (2016). Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: a mixed methods study. Health Policy, 120(1), 35-45. https://doi.org/10.1016/j.healthpol.2015.11.007
  • Jackson, Timothy L., Nicod, Elena, Angelis, Aris, Grimaccia, Federico, Prevost, Andrew T., Simpson, Andrew R.H., Kanavos, Panos (2013). Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy. Retina, 33(10), 2012-2017. https://doi.org/10.1097/IAE.0b013e3182a6b3e2
  • Jackson, Timothy L., Nicod, Elena, Angelis, Aris, Grimaccia, Federico, Prevost, Toby, Simpson, Andrew, Kanavos, Panos (2013). Vitreous attachment in age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. Retina, 33(6), 1099-1108. https://doi.org/10.1097/IAE.0b013e31828991d6
  • Jackson, Timothy, Nicod, Elena, Simpson, Andrew, Angelis, Aris, Grimaccia, Federico, Kanavos, Panos (2013). Symptomatic vitreomacular adhesion. Retina, 33(8), 1503-1511. https://doi.org/10.1097/IAE.0b013e31829232fd
  • Nicod, Elena, Kanavos, Panos (2012). Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions. Health Policy, 108(2-3), 167-177. https://doi.org/10.1016/j.healthpol.2012.09.012
  • Kanavos, Panos, Nicod, Elena (2012). What is wrong with orphan drug policies?: suggestions for ways forward. Value in Health, 15(8), 1182-1184. https://doi.org/10.1016/j.jval.2012.08.2202
  • Nicod, Elena (2010). Harmonizing the outcomes of HTA: an application to central nervous system treatments. Euro Observer, 12(4), 9-14.
  • Kanavos, Panos, Nicod, Elena, van den Aardweg, Stacey, Pomedli, Stephen (2010). The impact of health technology assessments: an international comparison. Euro Observer, 12(4), 1-7.
    • Report
  • Kanavos, Panos, Nicod, Elena, Espin, Jaime, van den Aardweg, Stacey (2010). Short- and long-term effects of value-based pricingvs. external price referencing. EMiNet.
  • Kanavos, Panos, Vandoros, Sotiris, Irwin, Rachel, Nicod, Elena, Casson, Margaret (2010). The European pharmaceutical market and policies - outlook for the future. European Parliament.
    • Thesis
  • Gallmann, Elena (2015). A critical appraisal of coverage and resource allocation decisions through the use of health technology assessment: evidence on orphan drugs from four countries [Doctoral thesis]. London School of Economics and Political Science.